Risk factors and prodromal markers and the development of Parkinson’s disease

被引:0
|
作者
Stefanie Lerche
Klaus Seppi
Stefanie Behnke
Inga Liepelt-Scarfone
Jana Godau
Philipp Mahlknecht
Alexandra Gaenslen
Kathrin Brockmann
Karin Srulijes
Heiko Huber
Isabel Wurster
Heike Stockner
Stefan Kiechl
Johann Willeit
Arno Gasperi
Klaus Fassbender
Werner Poewe
Daniela Berg
机构
[1] University of Tuebingen,Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology
[2] University of Tuebingen,German Center for Neurodegenerative Diseases (DZNE)
[3] University of Innsbruck,Department of Neurology
[4] University of Homburg/Saar,Department of Neurology
[5] Bruneck Hospital,Department of Neurology
来源
Journal of Neurology | 2014年 / 261卷
关键词
Risk factor; Prodromal marker; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Identification of risk factors and prodromal markers for Parkinson’s disease (PD) and the understanding of the point in time of first occurrence is essential for the early detection of incident PD. In this three-center longitudinal, observational study, we evaluated the specific risk for PD associated with single or combinations of risk factors and prodromal markers. In addition, we evaluated which risk factors and prodromal markers emerge at which time before the diagnosis of PD. Of the 1,847 at-baseline PD-free individuals ≥50 years, 1,260 underwent the 5-year follow-up assessment. There were 21 cases of incident PD during the study period. Enlarged hyperechogenic substantia nigra was the most frequent baseline sign in individuals developing PD after 3 years (80.0 %) and 5 years (85.7 %) compared to healthy controls (17.5 %) followed by the occurrence of mild parkinsonian signs and hyposmia. Evaluation of the signs at the first follow-up assessment showed that individuals developing PD after two additional years showed the same pattern of signs as individuals who developed PD 3 years after baseline assessment.
引用
收藏
页码:180 / 187
页数:7
相关论文
共 50 条
  • [1] Risk factors and prodromal markers and the development of Parkinson's disease
    Lerche, Stefanie
    Seppi, Klaus
    Behnke, Stefanie
    Liepelt-Scarfone, Inga
    Godau, Jana
    Mahlknecht, Philipp
    Gaenslen, Alexandra
    Brockmann, Kathrin
    Srulijes, Karin
    Huber, Heiko
    Wurster, Isabel
    Stockner, Heike
    Kiechl, Stefan
    Willeit, Johann
    Gasperi, Arno
    Fassbender, Klaus
    Poewe, Werner
    Berg, Daniela
    JOURNAL OF NEUROLOGY, 2014, 261 (01) : 180 - 187
  • [2] Prodromal Markers of Parkinson's Disease
    Oertel, W.
    Vadasz, D.
    Ries, V.
    Mayer, G.
    Eggert, K. M.
    Krenzer, M.
    Unger, M. M.
    Hoeglinger, G. U.
    Mollenhauer, B.
    Sixel-Doering, F.
    Trenkwalder, C.
    Depboylu, C.
    AKTUELLE NEUROLOGIE, 2013, 40 (08) : 452 - 461
  • [3] Bayesian network modeling of risk and prodromal markers of Parkinson's disease
    Sood, Meemansa
    Suenkel, Ulrike
    von Thaler, Anna-Katharina
    Zacharias, Helena U. U.
    Brockmann, Kathrin
    Eschweiler, Gerhard W.
    Maetzler, Walter
    Berg, Daniela
    Froehlich, Holger
    Heinzel, Sebastian
    PLOS ONE, 2023, 18 (02):
  • [4] Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease
    Xie, Fen
    Gao, Xiaoya
    Yang, Wanlin
    Chang, Zihan
    Yang, Xiaohua
    Wei, Xiaobo
    Huang, Zifeng
    Xie, Huifang
    Yue, Zhenyu
    Zhou, Fengli
    Wang, Qing
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 973 - 990
  • [5] Clinical and Imaging Markers of Prodromal Parkinson's Disease
    Hustad, Eldbjorg
    Aasly, Jan O.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [6] Ultrasonography Markers in Prodromal Parkinson's disease (PD)
    Secades Garcia, S.
    Perez, J.
    La Casa, B.
    Contreras, A.
    Grandas, F.
    MOVEMENT DISORDERS, 2024, 39 : S484 - S484
  • [7] Risk Disclosure in Prodromal Parkinson's Disease
    Schaeffer, Eva
    Toedt, Inken
    Koehler, Susanne
    Rogge, Annette
    Berg, Daniela
    MOVEMENT DISORDERS, 2021, 36 (12) : 2833 - 2839
  • [8] Prodromal Parkinson's disease and subsequent risk of Parkinson's disease and mortality
    Chen, Xiao
    Li, Yaqi
    Shen, Yun
    Schwarzschild, Michael A.
    Gao, Xiang
    NPJ PARKINSONS DISEASE, 2025, 11 (01)
  • [9] Advances in markers of prodromal Parkinson disease
    Ronald B. Postuma
    Daniela Berg
    Nature Reviews Neurology, 2016, 12 : 622 - 634
  • [10] Advances in markers of prodromal Parkinson disease
    Postuma, Ronald B.
    Berg, Daniela
    NATURE REVIEWS NEUROLOGY, 2016, 12 (11) : 622 - 634